Current concepts of celiac disease pathogenesis

Gastroenterology

Volumn 119, Issue 1, 2000, Pages 234-242

  Schuppan, Detlef ^a  

^a UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ENDOMYSIUM ANTIBODY; GLUTEN; HLA DQ ANTIGEN; IMMUNOGLOBULIN A ANTIBODY; PROTEIN GLUTAMINE GAMMA GLUTAMYLTRANSFERASE;

ANTIGEN PRESENTATION; ANTIGEN PRESENTING CELL; AUTOIMMUNE DISEASE; CELIAC DISEASE; DISEASE PREDISPOSITION; ENVIRONMENTAL FACTOR; HEREDITY; IMMUNE RESPONSE; INFLAMMATION; LAMINA PROPRIA; LYMPHOID TISSUE; MALABSORPTION; PATHOGENESIS; PRIORITY JOURNAL; REVIEW; T LYMPHOCYTE ACTIVATION;

EID: 0034235978     PISSN: 00165085     EISSN: None     Source Type: Journal    
DOI: 10.1053/gast.2000.8521     Document Type: Article

References (64)

1. Thomas C. On the coeliac affection. In: Major RH, ed. Classic Descriptions of Disease. Springfield, IL: Charles C. Thomas, 1945;600-601.
2. Gee S. On the coeliac affection. St Bartholomews Hosp Rep 1888;24:17-20.
3. Benecke R. Ueber die Spruekrankheit (Aphthae tropicae). Verh Dtsch Ges Pathol 1910;14:132.
4. Haas SV. Celiac disease, its specific treatment and cure without nutritional relapse. JAMA 1932;99:448-452.
5. Dicke WK. Investigation of the Harmful Effects of Certain Types of Cereal on Patients with Coeliac Disease [doctoral thesis]. University of Utrecht, the Netherlands, 1950.
6. Van de Kamer JH, Weyers HA, Dicke WK. Coeliac disease IV. An investigation into the injurious constituents of wheat in connection with their action on patients with coeliac disease. Acta Paediatr Scand 1953;42:223-231.
7. Paulley LW. Observations on the aetiology of idiopathic steatorrhoea. Br Med J 1954;2:1318-1321.
8. Rubin C, Brandborg LL, Phelps PC, Taylor HC. Studies of celiac disease. Part I. The apparent identical and specific nature of the duodenal and proximal jejunal lesion in celiac disease and idiopathic sprue. Gastroenterology 1960;38:28-38.
9. McDonald WC, Dobbins WO III, Rubin CE. Studies of the familial nature of celiac sprue using biopsy of the small intestine. N Engl J Med 1965;272:448-456.
10. Marks J, Schuster S, Watson AJ. Small bowel changes in dermatitis herpetiformis. Lancet 1966;2:1280-1282.
11. Harris OD, Cooke WT, Thompson JA, Waterhouse A. Malignancy in adult coeliac disease and idiopathic steatorrhea. Am J Med 1967;42:899-912.
12. Mawhinney H, Tomkin GH. Gluten enteropathy associated with selective IgA deficiency. Lancet 1971;2:121-124.
13. Ferguson A, MacDonald TT, McClure JP, Holden RJ. Cell-mediated immunity to gliadin within the small-intestinal mucosa in coeliac disease. Lancet 1975;1:895-897.
14. Howell MD, Austin RK, Kelleher D, Nepom GT, Kagnoff MF. An HLA-D region restriction length polymorphism associated with celiac disease. J Exp Med 1986;164:333-339.
15. Sollid L, Markussen G, Ek J, Gjerde H, Vartdal F, Thorsby E. Evidence for a primary association of celiac disease to a particular HLA-DQ-α/β heterodimer. J Exp Med 1989;169:345-350.
16. Spencer J, Issacson PJ, Diss TC, MacDonald TT. Expression of disulfide-linked and non-disulfide-linked forms of the T cell receptor gamma/delta heterodimer in human intestinal intraepithelial lymphocytes. Eur J Immunol 1989;19:1335-1338.
17. Marsh MN. Gluten, major histocompatibility complex, and the small intestine: A molecular and immunobiologic approach to the spectrum of gluten sensitivity ('celiac sprue'). Gastroenterology 1992;102:330-354.
18. Lundin KE, Scott H, Hansen T, Paulsen G, Halstensen TS, Fausa O, Thorsby E, Sollid LM. Gliadin-specific, HLA-DQ (alpha*0501, beta*0201) restricted T cells isolated from the small intestinal mucosa of celiac disease patients. J Exp Med 1993;178:187-196.
19. Seah PP, Fry LL, Rossiter MA, Hoffbrand AV, Holborow EJ. Anti-reticulin antibodies in childhood celiac disease. Lancet 1971;2:681-682.
20. Chorzelski TP, Sulej J, Tchorzewska H, Jablonska S, Beutner EH, Kumar V. Iga class endomysium antibodies in dermatitis herpetiformis and coeliac disease. Ann N Y Acad Sci 1983;420:325-334.
21. Ladinser B, Rossipal E, Pittschieler K. Endomysium antibodies in coeliac disease: An improved method. Gut 1994;35:776-778.
22. Dieterich W, Ehnis T, Bauer M, Donner P, Volta U, Riecken EO, Schuppan D. Identification of tissue transglutaminase as the autoantigen of celiac disease. Nat Med 1997;3:797-801.
23. Cornell H, Wieser H, Belitz HD. Characterization of the gliadin-derived peptides which are biologically active in coeliac disease. Clin Chim Acta 1992;213:37-50.
24. Wieser H. The precipitating factor in coeliac disease. Baillieres Clin Gastroenterol 1995;9:191-207.
25. De Vincenzi M, Luchetti R, Peruffo AD, Curioni A, Pogna NE, Gasbarrini G. In vitro assessment of acetic acid-soluble proteins (glutenin) in celiac disease. J Biochem Toxicol 1996;11:205-210.
26. Field JM, Shewry PR, Miflin BJ. The purification and characterization of homologous high molecular weight storage proteins from grains of wheat, rye and barley. Theor Appl Genet 1982;62:329-336.
27. Janatuinen EK, Pikkarainen PH, Kemppainen TA, Kosma VM, Järvinen RM, Uusitupa MI, Julkunen RJ. A comparison of diets with and without oats in adults with celiac disease. N Engl J Med 1995;333:1033-1037.
28. Ellis HJ, Rosen-Bronson S, O'Reilly N, Ciclitira PJ. Measurement of gluten using a monoclonal antibody to a coeliac toxic peptide of A-gliadin. Gut 1998;43:190-195.
29. van Overbeek FM, Uil-Dieterman IG, Mol IW, Kohler-Brands L, Heymans HS, Mulder CJ. The daily gluten intake in relatives of patients with coeliac disease compared with that of the general dutch population. Eur J Gastroenterol Hepatol 1997;9:1097-1099.
30. Faulkner-Hogg KB, Selby WS, Loblay RH. Dietary analysis in symptomatic patients with coeliac disease on a gluten-free diet: The role of trace amounts of gluten and non-gluten food intolerances. Scand J Gastroenterol 1999; 34:784-789.
31. Greenberg DA, Lange KL. A maximum likelihood test of the two locus model for celiac disease. Am J Med Genet 1982;12:75-82.
32. Houlston RS, Tomlinson IPM, Ford D, Seal S, Marossy AM, Ferguson A, Holmes GKT, Hosie KB, Howdle PD, Jewell DP, Godkin A, Kerr GD, Kumar P, Logan RFA, Love AHG, Johnston S, Marsh MN, Mitton S, O'Donoghue D, Roberts A, Walker-Smith JA, Stratton MF. Linkage analysis of candidate regions for celiac disease genes. Hum Mol Genet 1997;6:1335-1339.
33. Greco L, Corazza G, Babron MC, Clot F, Fulchignoni-Lataud MC, Percopo S, Zavattari P, Bouguerra F, Dib C, Tosi R, Troncone R, Ventura A. Genome search in celiac disease. Am J Hum Genet 1998;62:669-675.
34. Weile B, Cavell B, Nivenius K, Krasilnikoff PR. Striking difference in the incidence of childhood celiac disease between Denmark and Sweden: A plausible explanation. J Pediatr Gastroenterol 1995;21:64-68.
35. Ascher H. The role of quantity and quality of gluten-containing cereals in the epidemiology of coeliac disease. In: Mäki M, Collin P, Visakorpi JK, eds. Coeliac Disease. Vammala, Finland: Vammalan Kirjapaino, 1997:15-22.
36. Corrao G, Corazza GR, Andreani ML, Torchio P, Valentini RA, Galatola G, Quaglino D, Gasbarrini G, di Orio F. Serological screening of coeliac disease: Choosing the optimal procedure according to various prevalence values. Gut 1994;35:771-775.
37. Catassi C, Ratsch IM, Fabiani E, Rossini M, Bordicchia F, Candela F, Coppa GV, Giorgi PL. Coeliac disease in the year 2000: Exploring the iceberg. Lancet 1994;343:200-203.
38. Ventura A, Magazzu G, Greco L, and the SIGEP study group. Duration of exposure to gluten and risk for autoimmune disorders in patients with celiac disease. Gastroenterology 1999;117:297-303.
39. Greenberg CS, Birkbichler PJ, Rice RH. Transglutaminases: Multifunctional cross-linking enzymes that stabilize tissues. FASEB J 1991;5:3071-3077.
40. Piacentini M, Colizzi V. Tissue transglutaminase: Apoptosis versus autoimmunity. Immunol Today 1999;3:130-134.
41. Schuppan D, Ehnis T, Bauer M, Volta A, Donner P, Riecken EO, Dieterich W. Identification of the autoantigen of coeliac disease. Ann N Y Acad Sci 1998;859:121-126.
42. Bruce SE, Bjarnason I, Peters TJ. Human jejunal transglutaminase: Demonstration of activity, enzyme kinetics and substrate specificity with special relation to gliadin and coeliac disease. Clin Sci 1985;68:S73-S79.
43. Szabolcs M, Sipka S, Csorba S. In vitro cross-linking of gluten into high molecular weight polymers with transglutaminase. Acta Paediatr Hung 1987;28:215-227.
44. Johannsen BH, Vartdal F, Eriksen JA, Thorsby E, Sollid LM. Identification of a putative motif for binding of peptides to HLA-DQ2. Int Immunol 1996;8:177-182.
45. Molberg Ø, MacAdam SN, Korner R, Quarsten H, Christiansen C, Madsen L, Fugger L, Scott H, Noren O, Roepstorff P, Lundin KEA, Sjøstrom H, Sollid L. Tissue transglutaminase selectively modifies gliadin peptides that are recognized by gut-derived T cells in celiac disease. Nat Med 1998;4:713-717.
46. Van de Wal Y, Kooy Y, van Veelen P, Pena S, Mearin L, PapadopouLos G, Koning F. Selective deamidation by tissue transglutaminase strongly enhances gliading-specific T cell reactivity. J Immunol 1998;161:1585-1588.
47. Sollid LM. Autoantibodies in coeliac disease: Tissue transglutaminase-guilt by association? Gut 1997;47:851-852.
48. Pender SL, Tickle SP, Docherty AJ, Howie D, Wathen NC, McDonald TT. A major role of matrix metalloproteinases in T cell injury in the gut. J Immunol 1997;158:1582-1590.
49. Daum S, Bauer U, Foss HD, Schuppan D, Stein H, Riecken EO, Ullrich R. Increased expression of mRNA for matrix metalloproteinase-1 and -3 and tissue inhibitor of metalloproteinases-1 in intestinal biopsy specimens from patients with coeliac disease. Gut 1999;44:17-25.
50. Bajaj-Elliott M, Poulsom R, Pender SL, Wathen NC, McDonald TT. Interactions between stromal cell-derived keratinocyte growth factor and epithelial transforming growth factor in immunemediated crypt cell hyperplasia. J Clin Invest 1999;102:1473-1480.
51. Halttunen T, Mäki M. Serum IgA from patients with celiac disease inhibits human T84 intestinal crypt epithelial cell differentiation. Gastroenterology 1999;116:566-572.
52. Dignass AU, Podolsky DK. Cytokine modulation of intestinal epithelial cell restitution: Central role of transforming growth factor beta. Gastroenterology 1993;105:1323-1332.
53. Nunes I, Gleizes PE, Metz CN, Rifkin DB. Latent transforming growth factor binding protein domains involved in activation and transglutaminase-dependent crosslinking of latent transforming growth factor-beta. J Cell Biol 1997;136:1151-1163.
54. King DP, Hyde DM, Jackson KA, Novosad DM, Ellis TN, Putney L, Stovall MY, Van Winkle LS, Beaman BL, Ferrick DA. Protective response to pulmonary injury requires gamma delta T lymphocytes. J Immunol 1999;162:5033-5036.
55. Mak TW, Ferrick DA. The γ/δT-cell bridge: Linking innate and acquired immunity. Nat Med 1998;7:764-765.
56. Groh V, Steinle A, Bauer S, Spies T. Recognition of stress-induced MHC molecules by intestinal epithelial γ/δ T cells. Science 1998;279:1737-1740.
57. Bauer S, Groh V, Wu J, Steinle A, Philipps JH, Lanier LL, Spies T. Activation of NK cells by NKG2D, a receptor for stress-induced MICA. Science 1999;285:727-729.
58. Dieterich W, Laag E, Schöpper H, Volta U, Ferguson A, Gillet H, Riecken EO, Schuppan D. Autoantibodies to tissue transglutaminase as predictors of coeliac disease. Gastroenterology 1998;115:1317-1321.
59. Sulkanen S, Halttunen T, Laurila K, Kolho KL, Korponay-Szabo IR, Sarnesto A, Savilahti E, Collin P, Mäki M. Tissue transglutaminase autoantibody enzyme-linked immunosorbent assay in detecting celiac disease. Gastroenterology 1998;115:1322-1328.
60. Seissler J, Borns S, Wohlrab U, Morgenthaler NG, Mothes T, Boehm BO, Scherbaum WA. Antibodies to human tissue transglutaminase measured by radioligand assay: Evidence for high diagnostic sensitivity for celiac disease. Horm Metab Res 1999;31:375-379.
61. Mustalahti K, Collin P, Sievanen H, Mäki M. Osteopenia in patients with clinically silent celiac disease. Lancet 1999;354:744-745.
62. Kordonouri O, Dieterich W, Schuppan D, Weber G, Müller C, Sarioglu N, Becker M, Danne T. Autoantibodies to tissue transglutaminase are sensitive serological parameters for detecting silent celiac disease in patients with type 1 diabetes. Diabetes Med (in press).
63. Not T, Horvath K, Hill ID, Partanen J, Mammed A, Magazzu G, Fasano A. Celiac disease in the USA: High prevalence of antiendomysium antibodies in healthy blood donors. Scand J Gastroenterol 1998;33:494-498.
64. Erb K. Atopic disorders: A default pathway in the absence of infection? Immunol Today 1999;7:317-322.